Cheung NK - Search Results

1

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ. Cheung NK, et al. Among authors: cheung iy. Med Pediatr Oncol. 2001 Jan;36(1):227-30. doi: 10.1002/1096-911X(20010101)36:1<227::AID-MPO1055>3.0.CO;2-U. Med Pediatr Oncol. 2001. PMID: 11464891 Clinical Trial.

2

Chronic neuroblastoma.

Kushner BH, Kramer K, Cheung NK. Kushner BH, et al. Among authors: cheung nk. Cancer. 2002 Sep 15;95(6):1366-75. doi: 10.1002/cncr.10800. Cancer. 2002. PMID: 12216106 Free article.

3

Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.

Modak S, Gerald W, Cheung NK. Modak S, et al. Among authors: cheung nk. Med Pediatr Oncol. 2002 Dec;39(6):547-51. doi: 10.1002/mpo.10151. Med Pediatr Oncol. 2002. PMID: 12376975

4

Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.

Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK. Kushner BH, et al. Among authors: cheung nk. J Clin Oncol. 2003 Mar 15;21(6):1082-6. doi: 10.1200/JCO.2003.07.142. J Clin Oncol. 2003. PMID: 12637474

5

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.

Cheung IY, Lo Piccolo MS, Kushner BH, Kramer K, Cheung NK. Cheung IY, et al. Among authors: cheung nk. J Clin Oncol. 2003 Mar 15;21(6):1087-93. doi: 10.1200/JCO.2003.02.055. J Clin Oncol. 2003. PMID: 12637475

6

Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification.

Kushner BH, LaQuaglia MP, Modak S, Cheung NK. Kushner BH, et al. Among authors: cheung nk. Med Pediatr Oncol. 2003 Jul;41(1):80-2. doi: 10.1002/mpo.10287. Med Pediatr Oncol. 2003. PMID: 12764755 No abstract available.

7

Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy.

Kushner BH, Kramer K, LaQuaglia MP, Cheung NK. Kushner BH, et al. Among authors: cheung nk. J Pediatr Hematol Oncol. 2003 Jul;25(7):515-9. doi: 10.1097/00043426-200307000-00003. J Pediatr Hematol Oncol. 2003. PMID: 12847316

8

Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.

Kramer K, Kushner BH, Cheung NK. Kramer K, et al. Among authors: cheung nk. J Pediatr Hematol Oncol. 2003 Aug;25(8):601-5. doi: 10.1097/00043426-200308000-00003. J Pediatr Hematol Oncol. 2003. PMID: 12902911

9

Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.

Cheung IY, Lo Piccolo MS, Kushner BH, Cheung NK. Cheung IY, et al. Among authors: cheung nk. J Clin Oncol. 2003 Oct 15;21(20):3853-8. doi: 10.1200/JCO.2003.11.077. J Clin Oncol. 2003. PMID: 14551304

10

Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Cheung NK. Kushner BH, et al. Among authors: cheung nk. Med Pediatr Oncol. 2003 Dec;41(6):508-15. doi: 10.1002/mpo.10273. Med Pediatr Oncol. 2003. PMID: 14595707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

505 results

Search Page